Chennai, Mumbai,31 October 2012: Trivitron Healthcare Private Limited (Trivitron) announced today that Fidelity Growth Partners India (FGPI) hasanchored a round of investment.This investment also provides partial exits for ePlanet Ventures and Headland Capital, who have been invested in Trivitron since 2007.For the past fifteen years, Trivitronhas been India's largest exclusive pan India wholesale distributor and after-sales support provider of medical equipment and devices. Its areas of expertise include imaging, lab diagnostics, cardiology, critical care,renal care, operating room and ophthalmology equipment. Trivitron is the partner of choice for anyforeign manufacturer looking to enter the country on account of its strong reputation and track record, national sales-and-service network and robust logistics infrastructure.Over the past few years, subsidiaries and joint ventures of Trivitron havebeen steadily laying the foundations for manufacturing medical equipment. Trivitron Medical Technology Park, a 25-acre state-of-the-art manufacturing facility in Chennai, was established in 2009 to house over 15 different medical technology manufacturing facilities of Trivitron's subsidiaries and joint ventures;Trivitron's joint ventures with Hitachi-Aloka (Japan) for manufacturing ultrasound equipment and with Biosystems (Spain) for lab diagnostics reagents are already operational.The company has recently set up centres of innovationfor biomedical equipment in collaboration with the Indian Institute of Technology (IIT), Chennai and under the leadership of its Director (R&D), Prof. Bhuvaneshwar, a wellrecognized innovator in this area.With the new fund infusion into the company, Trivitron aims to become a global player in the imaging and labdiagnosticssegments through organic growth as well as through acquisition of companies and technologies in Europe and the United States. The funds will be used to increase Trivitron's shareholding in Kiran Medical Systems, an international player in imaging accessories, expanding operations at Trivitron Medical Technology Park, and enhancing the company's distribution operations in South East Asia, Middle East and Africa. Trivitron was founded in 1997 by Dr. G.S.K. Velu after his stint as the Country Head for Chiron Diagnostics, before embarking on a successful entrepreneurial journey. In addition to Trivitron, Dr. Velu has co-founded and built the country's leading path lab chain, Metropolis Healthcare, as well as Medfort, a chain of single specialty, eye-care and diabetes-care hospitals. He has also co-founded a joint venture with the Apollo Hospitals Group for dental clinics(Apollo White) and dialysis centres (Apollo Dialysis). Commenting on the transaction, Mr. Raj Dugar, Senior Managing Director at FIL Capital Advisors (India) Private Limited, the private equity advisory arm for FGPI, said, "We are very excited to partner with Dr. Velu and Trivitron. Trivitron has a presence in both value and premium segments, and offers an excellent portfolio of products across India. The medical equipment sector in the country is still nascent and dominated by imports. We believe that India will follow the same evolution trajectory as other emerging markets like China where large, indigenous manufacturers of medical equipment have emerged over the past decade. Trivitron is well positioned to capitalize on this trend with its unparalleled distribution and service infrastructure that is difficult to replicate. High quality manufacturing efforts of Trivitron'ssubsidiaries and joint ventureswill allow Trivitron to expand its product portfolio to all segments of the market.'Dr. Velu said, 'We are excited to have Fidelity as new investors and board members in Trivitron. Fidelity with its vast knowledge in the medical devices space in China, USA, and Europe will be able to add substantial value to Trivitron in becoming a global player in the imaging and lab diagnostics segments.Fidelity's long-standing experience in China would also help us in making in-roads in the value segment.I am certain that Fidelity's guidance would be invaluable in helping Trivitron implement its strong growth plan.' Kotak Mahindra Capital Company (KMCC), the investment banking arm of Kotak Mahindra Bank, was the exclusive advisor to Trivitron on the transaction. Amarchand &Mangaldas& Suresh A. Shroff& Co. acted as the company's legal counsel. Notes to the editor: About Fidelity Growth Partners India Fidelity Growth Partners India (FGPI) is the India-focused private equity arm of Fidelity Worldwide Investment, focused on cross-sector growth capital investing. FGPI seeks to invest in high-quality, high-growth companies in India across a broad range of sectors with typical investment sizes ranging from $10 million to $50 million. FGPI is committed to making the companies it invests in leaders in their industries through access to patient capital with a long term investment mindset, a powerful network of resources and a team of investment professionals with a proven track record of success. Fidelity, Fidelity Worldwide Investment and Fidelity Growth Partners India are trademarks of FIL Limited. Media contact person: Mr Arijit Sengupta Direct: 22 6655 4057 Mob: 98203 40485 Email: arijit.sengupta@fil.com